UiPath shares have had a tough start to the year, but the company has a big potential opportunity ahead.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

On March 12, 2026, investors weighed UiPath’s first full-year profit against slowing growth and divided Wall Street views.

UiPath (NYSE:PATH) has launched agentic AI automation tools tailored for healthcare providers and payers. The company is partnering with Genzeon to target data management and revenue cycle workflows.

Chris Ashley, Director of BD & Strategy at UiPath, doesn't mince words about where most organizations actually stand on data ...

UiPath is a leader in Robotic Process Automation. The company plans to decentralize, improve sales fundamentals, and innovate in AI and automation to address execution challenges. Despite recent ...

Payments and data company recognized as one of the 25 most innovative UiPath customers using AI and automation The UiPath AI25 Awards acknowledge customers using AI and automation to supercharge ...

Integration demonstrates the power of agentic automation and security platforms working together to protect modern enterprises ...

UiPath Inc. today announced a preview of its upcoming Agent Builder tool as it outlined its vision to combine its expertise in robotic process automation with generative artificial intelligence models ...

UiPath almost doubled over the past year thanks to its strong quarterly results and enthusiasm surrounding AI stocks. The company has plenty of room to grow as it pursues its $61 billion total ...